BioCentury | Feb 12, 2007
Company News

Advanced Cell Technology, Infigen deal

...ACTC purchased Infigen's IP in an auction for undisclosed amounts of cash and stock. Infigen's 26...
...out-license the technology for use in animals. Further details were not disclosed. In January 2004, Infigen...
...its staff because of a lack of funds. Advanced Cell Technology Inc. (ACTC), Alameda, Calif. Infigen Inc....
BioCentury | Jul 19, 2004
Company News

Infigen, Pharming Group NV deal

...The companies completed their previously announced deal under which PHARM obtains worldwide, non-exclusive licenses from Infigen...
...royalty- and milestone-free. The deal supersedes the companies' earlier agreements (see BioCentury, Oct. 28, 2002). Infigen Inc....
BioCentury | May 24, 2004
Company News

Infigen, Pharming Group NV, ProBio Inc. deal

...PHARM will obtain access to Infigen's IP relating to protein production for an undisclosed sum. The...
...The deal supercedes the companies' earlier agreements and releases PHARM from paying future milestones to Infigen...
...45% from 20%. The companies partnered to develop and commercialize recombinant human lactoferrin in Asia. Infigen Inc....
BioCentury | May 10, 2004
Company News

Immerge BioTherapeutics Inc., Infigen other research news

...SWX:NOVN, Basel, Switzerland) and BioTransplant Inc. (BTRN, Medford, Mass.). Immerge BioTherapeutics Inc. , Cambridge, Mass. Infigen Inc....
BioCentury | Feb 2, 2004
Company News

Geron, Infigen gene/cell therapy news

...Trademark Office's Board of Patent Appeals and Interferences finalized its January ruling that claims of Infigen's...
...animal cloning technology are unpatentable (see BioCentury, Jan. 19). Geron Corp. (GERN), Menlo Park, Calif. Infigen Inc....
BioCentury | Jan 19, 2004
Company News

Geron, Infigen gene/cell therapy news

...U.S. Patent and Trademark Office's Board of Patent Appeals and Interferences ruled that claims of Infigen's...
...application for animal cloning technology are unpatentable. The interference proceeding relates to patent applications from Infigen...
...cover the use of nuclear transfer for animal cloning. Geron Corp. (GERN), Menlo Park, Calif. Infigen Inc....
BioCentury | Mar 31, 2003
Company News

Advanced Cell Technology, Infigen gene/cell therapy news

...Advanced Cell Technology Inc. , Worcester, Mass. Infigen Inc. , DeForest, Wis. Business: Gene/Cell therapy The U.S...
...that claims in an Infigen patent are barred. The board held that claims of the Infigen...
...licensed to Advanced Cell. As a result, the board terminated the patent interference requested by Infigen...
BioCentury | Oct 28, 2002
Company News

Infigen, Pharming Holding N.V. deal

...that use Infigen's technology. PHAR will pay Infigen in cash and PHAR shares. Last year, Infigen...
...Oct. 22, 2001). Infigen said PHAR must stop using Infigen technology that PHAR previously licensed. Infigen Inc....
BioCentury | Jul 8, 2002
Company News

Advanced Cell Technology, Infigen gene/cell therapy news

...Court in Worcester, Mass. ruled that a 1999 settlement grants Advanced Cell a license to Infigen's...
...result, Infigen has been ordered to provide copies of its patent applications to Advanced Cell. Infigen...
...Advanced Cell to technology contained within its patent applications only after publication of the application. Infigen...
BioCentury | Feb 19, 2002
Company News

Infigen other research news

...born. The company said that all piglets were healthy at least 1 month after birth. Infigen Inc....
Items per page:
1 - 10 of 43
BioCentury | Feb 12, 2007
Company News

Advanced Cell Technology, Infigen deal

...ACTC purchased Infigen's IP in an auction for undisclosed amounts of cash and stock. Infigen's 26...
...out-license the technology for use in animals. Further details were not disclosed. In January 2004, Infigen...
...its staff because of a lack of funds. Advanced Cell Technology Inc. (ACTC), Alameda, Calif. Infigen Inc....
BioCentury | Jul 19, 2004
Company News

Infigen, Pharming Group NV deal

...The companies completed their previously announced deal under which PHARM obtains worldwide, non-exclusive licenses from Infigen...
...royalty- and milestone-free. The deal supersedes the companies' earlier agreements (see BioCentury, Oct. 28, 2002). Infigen Inc....
BioCentury | May 24, 2004
Company News

Infigen, Pharming Group NV, ProBio Inc. deal

...PHARM will obtain access to Infigen's IP relating to protein production for an undisclosed sum. The...
...The deal supercedes the companies' earlier agreements and releases PHARM from paying future milestones to Infigen...
...45% from 20%. The companies partnered to develop and commercialize recombinant human lactoferrin in Asia. Infigen Inc....
BioCentury | May 10, 2004
Company News

Immerge BioTherapeutics Inc., Infigen other research news

...SWX:NOVN, Basel, Switzerland) and BioTransplant Inc. (BTRN, Medford, Mass.). Immerge BioTherapeutics Inc. , Cambridge, Mass. Infigen Inc....
BioCentury | Feb 2, 2004
Company News

Geron, Infigen gene/cell therapy news

...Trademark Office's Board of Patent Appeals and Interferences finalized its January ruling that claims of Infigen's...
...animal cloning technology are unpatentable (see BioCentury, Jan. 19). Geron Corp. (GERN), Menlo Park, Calif. Infigen Inc....
BioCentury | Jan 19, 2004
Company News

Geron, Infigen gene/cell therapy news

...U.S. Patent and Trademark Office's Board of Patent Appeals and Interferences ruled that claims of Infigen's...
...application for animal cloning technology are unpatentable. The interference proceeding relates to patent applications from Infigen...
...cover the use of nuclear transfer for animal cloning. Geron Corp. (GERN), Menlo Park, Calif. Infigen Inc....
BioCentury | Mar 31, 2003
Company News

Advanced Cell Technology, Infigen gene/cell therapy news

...Advanced Cell Technology Inc. , Worcester, Mass. Infigen Inc. , DeForest, Wis. Business: Gene/Cell therapy The U.S...
...that claims in an Infigen patent are barred. The board held that claims of the Infigen...
...licensed to Advanced Cell. As a result, the board terminated the patent interference requested by Infigen...
BioCentury | Oct 28, 2002
Company News

Infigen, Pharming Holding N.V. deal

...that use Infigen's technology. PHAR will pay Infigen in cash and PHAR shares. Last year, Infigen...
...Oct. 22, 2001). Infigen said PHAR must stop using Infigen technology that PHAR previously licensed. Infigen Inc....
BioCentury | Jul 8, 2002
Company News

Advanced Cell Technology, Infigen gene/cell therapy news

...Court in Worcester, Mass. ruled that a 1999 settlement grants Advanced Cell a license to Infigen's...
...result, Infigen has been ordered to provide copies of its patent applications to Advanced Cell. Infigen...
...Advanced Cell to technology contained within its patent applications only after publication of the application. Infigen...
BioCentury | Feb 19, 2002
Company News

Infigen other research news

...born. The company said that all piglets were healthy at least 1 month after birth. Infigen Inc....
Items per page:
1 - 10 of 43